BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12796588)

  • 41. The cyclin-dependent kinase inhibitor, p27, has no correlation with the malignant potential of GIST.
    Shirin H; Kravtsov V; Shahmurov M; Shabat VS; Krinshpon I; Alin A; Avinoach I; Avni Y
    Digestion; 2007; 75(1):4-9. PubMed ID: 17406118
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Importance of proliferation markers in gastrointestinal carcinoid tumors: a clinicopathologic study.
    Sökmensüer C; Gedikoglu G; Uzunalimoglu B
    Hepatogastroenterology; 2001; 48(39):720-3. PubMed ID: 11462912
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunohistochemistry and c-kit gene analysis in determining malignancy in gastrointestinal stromal tumors.
    Yamaguchi M; Tate G; Endo Y; Miyaki M
    Hepatogastroenterology; 2003; 50(53):1431-5. PubMed ID: 14571755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Are there any prognostic factors for small intestinal stromal tumors?
    Bucher P; Taylor S; Villiger P; Morel P; Brundler MA
    Am J Surg; 2004 Jun; 187(6):761-6. PubMed ID: 15191872
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The significance of CD44 expression in gastrointestinal neuroendocrine tumors.
    Lai CH; Shan YS; Sy ED; Hsieh YH; Tsai HW; Lee JC; Lin PW
    Hepatogastroenterology; 2005; 52(64):1071-6. PubMed ID: 16001632
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
    Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trends in incidence and survival of mesenchymal neoplasm of the digestive tract within a defined population of northern Norway.
    Steigen SE; Eide TJ
    APMIS; 2006 Mar; 114(3):192-200. PubMed ID: 16643186
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis.
    Hassan I; You YN; Shyyan R; Dozois EJ; Smyrk TC; Okuno SH; Schleck CD; Hodge DO; Donohue JH
    Ann Surg Oncol; 2008 Jan; 15(1):52-9. PubMed ID: 18000711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of alpha6 integrin subunit is associated with malignancy in gastric gastrointestinal stromal tumors.
    Takeyama H; Funahashi H; Sawai H; Takahashi H; Yamamotorm M; Akamo Y; Manabe T
    Med Sci Monit; 2007 Feb; 13(2):CR51-6. PubMed ID: 17261983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prognostic factors of gastrointestinal stromal tumors of the stomach].
    Hillemanns M; Päsold S; Böttcher K; Höfler H
    Verh Dtsch Ges Pathol; 1998; 82():261-6. PubMed ID: 10095444
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An audit of surgical management of gastrointestinal stromal tumours (GIST).
    Bucher P; Egger JF; Gervaz P; Ris F; Weintraub D; Villiger P; Buhler LH; Morel P
    Eur J Surg Oncol; 2006 Apr; 32(3):310-4. PubMed ID: 16414236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative analysis of prognostic indicators for sarcomas of the soft parts and the viscerae.
    Rudolph P; Bonichon F; Gloeckner K; Collin F; Chassevent A; Schmidt D; Coindre JM; Parwaresch R; Klöppel G
    Verh Dtsch Ges Pathol; 1998; 82():246-52. PubMed ID: 10095442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinicopathologic study of 275 cases of gastrointestinal stromal tumors: the experience at 3 large medical centers in Mexico.
    Alvarado-Cabrero I; Vázquez G; Sierra Santiesteban FI; Hernández-Hernández DM; Pompa AZ
    Ann Diagn Pathol; 2007 Feb; 11(1):39-45. PubMed ID: 17240306
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical implications of C-kit gene mutation in patients with large gastrointestinal stromal tumors.
    Lin SC; Liu CL; Wang TI; Chang WS; Tzen CY; Huang MJ
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1604-8. PubMed ID: 16928224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Meta-analytical study of gastrointestinal stromal tumors (GIST)].
    Liberati G; Lucchetta MC; Petraccia L; Nocchi S; Rosentzwig R; De Matteis A; Grassi M
    Clin Ter; 2003; 154(2):85-91. PubMed ID: 12856366
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach.
    Cho S; Kitadai Y; Yoshida S; Tanaka S; Yoshihara M; Yoshida K; Chayama K
    Int J Oncol; 2006 Jun; 28(6):1361-7. PubMed ID: 16685437
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Gastrointestinal stromal tumors: prognostic value of DNA analysis with flow cytometry and of classical clinicopathologic parameters].
    Tarroch X; Salas A; Olona M; Moragas A
    Med Clin (Barc); 1999 Jun; 112(20):761-6. PubMed ID: 10422056
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Histopathological and cytological findings in a case of gastrointestinal stromal tumor presenting in the pelvic cavity].
    Takekawa Y; Kimura M; Sakakibara M; Yoshii R; Yamashita Y
    Rinsho Byori; 2007 Jun; 55(6):535-9. PubMed ID: 17657986
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plexiform fibromyxoma: a distinctive benign gastric antral neoplasm not to be confused with a myxoid GIST.
    Miettinen M; Makhlouf HR; Sobin LH; Lasota J
    Am J Surg Pathol; 2009 Nov; 33(11):1624-32. PubMed ID: 19675452
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Revision of gastrointestinal mesenchymal tumours with CD117.
    de Schipper JP; Liem RS; van den Ingh HF; van der Harst E
    Eur J Surg Oncol; 2004 Nov; 30(9):959-62. PubMed ID: 15498641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.